Sign up for the QMED & MD+DI Daily newsletter.
2015 MDEA Finalists: Corindus CorPath 200
Corindus CorPath 200
May 1, 2015
1 Min Read
The Corindus CorPath 200 system, manufactured by Corindus Vascular Robotics (United States), is the first FDA-cleared system for robotic-assisted percutaneous coronary intervention procedures; it helps optimize clinical outcomes while protecting interventional cardiologists from radiation exposure during procedures. Supply/design credit: Farm Design Inc. |
You May Also Like